Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Geneticist Appointed as Hughes Investigator

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Neil Hunter has been named as a Howard Hughes Medical Institute investigator, an honor reserved for scientists who exhibit exceptionally original thinking.

Hunter studies the most fundamental processes of how genes are shuffled and passed to the next generation.

The HHMI will pay Hunter's salary and research laboratory expenses, including salaries for research staff, for five years. He will then have an opportunity to apply for renewal of the grant.

"I'm delighted to congratulate Professor Hunter on this appointment, which underlines the growing prestige and influence of UC Davis as a center for biomedical research," said UC Davis Chancellor Linda P.B. Katehi.

Hunter is the first UC Davis faculty member to be appointed to the prestigious HHMI Investigator program and one of just 27 new HHMI investigators announced today (May 9) from a field of 1,155 applicants. In 2009, Hunter was named an early career scientist by the institute.

"Being named as an HHMI investigator is an exceptional honor for Neil, as well as for the UC Davis College of Biological Sciences," said James E. K. Hildreth, dean of the college. "He is a leader in the field of DNA recombination and his research has major implications for understanding many diseases, including cancer. Support from HHMI will allow him to sustain his research excellence for many years to come."

Robert Tjian, HHMI president, said the organization has a very simple mission. "We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes," Tjian said.

Under the terms of the award, Hunter will be an employee of HHMI working at UC Davis. There are approximately 330 HHMI investigators in the U.S. who are urged to "take risks, to explore unproven avenues, and to embrace the unknown — even if it means uncertainty or the chance of failure," according to the institute's website. There are no annual reports, and investigators are free to explore and change their research direction.

Hunter said that being affiliated with HHMI has been one of the most rewarding experiences of his scientific career, and thanked those who have helped him along the way. "I would not have received this honor without the understanding, encouragement and support of my family, colleagues, department chairs and deans, both past and present," he said.

HHMI investigators are expected to devote about three-quarters of their time to research, but also to participate in other faculty duties including teaching and service.

Hunter is studying a fundamental problem in biology: how cells shuffle their DNA and distribute exactly the right number of chromosomes to each sperm or egg cell. When cells divide to make sperm and eggs, how do they make sure that each cell obtains one full set of chromosomes?

When this process goes wrong, it can lead to miscarriage and developmental defects such as Down syndrome. It is estimated that around half of the roughly 1 million miscarriages that occur in the U.S. each year are due to a chromosomal imbalance. The risk increases with the mother's age.

Organisms from yeast to humans make their gametes (spores in yeast, sperm and eggs in humans) through a process called meiosis. While most body cells contain pairs of each chromosome, sperm and eggs have one copy of each, so that the fertilized egg ends up with one set of chromosomes from each parent.

During meiosis, the matching pairs of maternal and paternal chromosomes line up together, and their DNA strands interact by a process called recombination. This allows the chromosomes to exchange DNA with their paired partner, an event called a crossover.

"Initially there are hundreds of DNA breaks throughout the chromosomes, but only a few become crossovers," Hunter said.

Crucially, there has to be at least one crossover between each chromosome pair, or they will not line up properly, and gametes will receive the wrong number of chromosomes.

"I'm interested in how crossovers are made — how the process is wired in such a way that each pair of chromosomes always gets at least one crossover, even through the total number of crossovers in a cell is quite low. It's a fundamental process that we’re far from understanding," Hunter said. The crossover process was first proposed in 1909 by Belgian scientist Frans Janssens, who observed crossovers in cells undergoing meiosis from the Californian salamander.

Hunter is also a member of the UC Davis Comprehensive Cancer Center. In 2011, two UC Davis plant biologists, Professor Jorge Dubcovsky, Department of Plant Sciences, and the late Simon Chan, Department of Plant Biology, were among the first-ever class of HHMI-GBMF investigators, funded jointly by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation to support research leading to improved crops.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Transcription Factor Isoforms Implicated in Colon Diseases
UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.
Thursday, May 19, 2016
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
Tuesday, April 26, 2016
Study Yields the Key to Effective Personalized Medicine
A team of UCLA bioengineers and surgeons has taken a major step toward making personalized medicine a reality.
Monday, April 11, 2016
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Monday, February 08, 2016
Science Magazine Names CRISPR ‘Breakthrough of the Year’
In its year-end issue, the journal Science chose the CRISPR genome-editing technology invented at UC Berkeley 2015’s Breakthrough of the Year.
Monday, December 21, 2015
CRISPR-Cas9 Helps Uncover Genetics of Exotic Organisms
A new study illustrates the ease with which CRISPR-Cas9 can knock out genes in exotic animals to learn how those genes control growth and development.
Friday, December 11, 2015
New Method for Screening Cancer Cells
Parallel microfiltration could lead to better treatments for a number of diseases, UCLA-led study says.
Thursday, December 03, 2015
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
Monday, November 23, 2015
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Monday, October 19, 2015
Crop Cure
Scientists in new center to use medical research techniques to help food crops withstand drought and climate change.
Friday, October 16, 2015
Rare Childhood Leukemia Reveals Surprising Genetic Secrets
A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.
Thursday, October 15, 2015
Double Enzyme Hit May Explain Common Cancer Drug Side Effect
Mouse study suggests genomic screening before treatment may help prevent anemia.
Wednesday, October 14, 2015
New Autism Genes Are Revealed in Largest-Ever Study
Work draws more detailed picture of genetic risk, sheds light on sex differences in diagnosis.
Wednesday, September 30, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
Friday, July 24, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!